Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New filler aims to restore youthful cheeks

NCT ID NCT06734351

Symptom relief Sponsor: AbbVie Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new injectable gel called NOA VOLUME against the well-known JUVÉDERM VOLUMA XC for improving mid-face volume loss. About 231 adults with moderate to severe cheek hollowing will receive injections, with optional touch-ups. The goal is to see if NOA VOLUME is as safe and effective as the current standard.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Hyaluronic acid (HA) injectable gel with lidocaine
What this could lead to
If it works, this could provide a safe, effective new option for restoring mid-face volume, similar to existing fillers.
What could go wrong
This is a Phase 3 trial comparing to an existing product, so it may not prove superior. Side effects like swelling, bruising, or lumpiness are possible with any injectable filler.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 231 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2024

Expected to finish

Jul 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

22 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Has moderate (3), significant (4), or severe (5) mid-face volume deficit on the 5-point photonumeric MFVDS based on evaluating investigator's (EI) live assessment. * Mid-face is amenable to achieving at least a 1-point improvement in MFVDS score with the allowed injection volume in the treating investigator's (TI) judgement. Exclusion Criteria: * Significant skin laxity in the midface in the opinion of the TI. * Significant skin pigmentation disorders or discoloration in the mid-face area that would interfere with the visual assessment of the mid-face area. * Current cutaneous inflammatory or infectious processes (e.g., acne, herpes), abscess, unhealed wound, or cancerous or precancerous lesion on the face.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Mid face volume deficit are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Mid face volume deficit

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    15 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Advanced Research Associates - Glendale /ID# 276812

    RECRUITING

    Glendale, Arizona, 85308, United States

  • Aesthetic Center at Woodholme /ID# 258166

    RECRUITING

    Baltimore, Maryland, 21208-6391, United States

  • Atlanta Biomedical Clinical Research /ID# 261210

    RECRUITING

    Atlanta, Georgia, 30331-2160, United States

  • Edwin F. Williams III, MD FACS of LATHAM P.C. D/B/A THE REJUVA CENTER /ID# 261211

    RECRUITING

    Latham, New York, 12110, United States

  • EthiQ2 Research, LLC /ID# 258906

    RECRUITING

    Brookfield, Wisconsin, 53005, United States

  • Hevia Cosmetic Dermatology /ID# 258165

    RECRUITING

    Coral Gables, Florida, 33134, United States

  • Jane Yoo MD /ID# 279811

    RECRUITING

    New York, New York, 10019, United States

  • Northwest Dermatology Institute /ID# 258167

    RECRUITING

    Portland, Oregon, 97210-2859, United States

  • Pure Dermatology /ID# 258168

    RECRUITING

    Metairie, Louisiana, 70001, United States

  • Skin Research Institute LLC /ID# 258158

    RECRUITING

    Coral Gables, Florida, 33146-1837, United States

  • SkinDC /ID# 258163

    RECRUITING

    Arlington, Virginia, 22209, United States

  • Susan H. Weinkle MD /ID# 258160

    RECRUITING

    Bradenton, Florida, 34209-5642, United States

  • Total Skin and Beauty Dermatology Center /ID# 258164

    RECRUITING

    Birmingham, Alabama, 35205, United States

  • West Dermatology La Jolla /ID# 278590

    RECRUITING

    San Diego, California, 92121, United States

  • Westlake Dermatology & Cosmetic Surgery - Westlake /ID# 258156

    RECRUITING

    Austin, Texas, 78746-4720, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.